Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine
- Written by Reporters
- Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2
- Commercial production will be conducted in Laupheim, Germany
- Rentschler Biopharma's innovative and highly flexible business model enables fast, high-quality, large-scale...